The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.
Paul
L C
LC
Department of Medicine, University of Calgary, Alberta, Canada.
Davidoff
A
A
Benediktsson
H
H
Issekutz
T B
TB
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016029:Receptors, Very Late Antigen / Q000276:immunology*; D013997:Time Factors
D000911:Antibodies, Monoclonal; D016169:Lymphocyte Function-Associated Antigen-1; D016029:Receptors, Very Late Antigen